Hodgkin Lymphoma

Shaping your forecasting.

Welcome to theHub

Hodgkin Lymphoma

Hodgkin’s Lymphoma (HL) is a cancer (also known as Hodgkin Disease, Hodgkin Lymphoma or Hodgkin’s Disease) of the lymphatic system and is one of two common types of cancers of the lymphatic system.

The inclusion of Reed Sternberg cells, a type of white blood cell called a B lymphocyte, helps clinicians to delineate HL from other types of lymphoma. The primary site for HL in most patients will be the lymph nodes in the neck, but as a cancer that affects the lymphatic system, it has the potential to start anywhere in the body at the same time and to spread to different organs. The most common symptom of HL is painless swelling of the lymph nodes, however there are other signs that can indicate HL, including:

Night sweats
Itchy skin
Unexplained fever
Unintended weight loss
Persistent cough
Pain in the lymph nodes after consuming alcohol
Enlarged spleen

Epidemiology Data

Data Available: Incidence Data

Data covers: Males and Females (where applicable) from 2010 to 2050.

Data is split into 5 year age ranges (0-4, 5-9 etc) from 0 to 100+ years, across multiple countries.

Additional sub filters of the data are available. Please see the below pop up box for more information.

Once purchased, the data will be provided in an embedded PowerBI document, in which the data can be filtered and viewed in a way which suits your needs. Raw data can also be downloaded. Below is an example embedded data set which can be filtered in a similar way.

Once the data set has been purchased, please refresh this page. The example data set will then be replaced with actual data.

Please contact us for further information regarding filtering of the data, viewing the data, data available, custom quotes, or anything else.

As well as incidence, data can be filtered by the following attributes:

• 1L / 2L / 3L treatment eligible
• Cachexia
• EBV-associated Hodgkins lymphoma
• Haemolytic anaemia
• International Prognosis Index Score Score
• Stage I
• Subtype Lymphocyte-depleted
• Subtype Lymphocyte-rich / Predominant
• Subtype Mixed-cellularity
• Subtype Nodular Lymphocyte Predominant
• Subtype Nodular Sclerosing
• Subtype NOS
• Systemic Symptoms at Diagnosis

Further sub sets are available within the data, please contact us for more information.

Republic of Korea
Russian Federation
Saudi Arabia
South Africa
United Kingdom
United States of America

The more you buy, the more you save*

*discount added at checkout

For all your pharmaceutical
forecasting needs.

theHub is a portal of resources to help you create better forecasting. Courses, templates, software, data and working model examples to get you on the path to better forecasting. Sign up now to get access to a world of interactive content.

About J+D Forecasting.

At J+D it's our mission to simplify the complex nature of pharmaceutical forecasting to help support informed decision making for the future. We are dedicated to helping pharmaceutical and biotech companies use intelligent forecasting solutions to make strategic and operational investment decisions.

For decades, we have crafted bespoke pharmaceutical forecasting models, innovative software and interactive training solutions, each of which has been designed with client needs in mind, allowing businesses to create more intelligent and consistent insights.